Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a ...
Early trials, according to The New York Times, have shown that people with obesity and knee osteoarthritis lost 28.7 percent of their body weight after taking the highest dose for nearly 70 weeks, ...
For every life-changing new drug that comes to market, many candidates fail along the way. An artificial intelligence-based ...
University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery ...
TAIPEI, March 5, 2026 /PRNewswire/ -- Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator ...
The US Food and Drug Administration (FDA) has issued draft guidance on developing cancer drugs intended for use in combination with other therapies. The guidance focuses on demonstrating each drug's ...
New draft guidance from the US Food and Drug Administration (FDA) aims to assist sponsors and pharmaceutical manufacturers in the development of drugs to treat complicated urinary tract infections ...
Better cancer care depends on better treatment options. That’s why the Ontario Institute for Cancer Research (OICR) is supporting four Ontario-based research teams working to develop the next ...
(Bloomberg) -- Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding its portfolio of oncology treatments. Based in the UK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results